Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

clearance   save search

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
BRTX | $1.39 83K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 9.23% H: 15.49% C: -7.75%

brtx-100 fda clearance study
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
DDD F | $3.46 2.07% 250K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 5.95% H: 0.26% C: -9.95%

fda first clearance for
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.5195 3.59% 210K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.11% H: 5.95% C: -13.78%

mc138 fda ttx-mc138 tumors clearance trial therapeutics advanced
Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.385 -3.82% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 26.42% H: 3.48% C: -6.47%

ocu400 fda first clearance trial therapy
iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency in the U.S.
Published: 2024-04-04 (Crawled : 23:00) - biospace.com/
DTIL | $11.41 -0.87% 30K twitter stocktwits trandingview |
Health Technology
| | O: -2.33% H: 1.64% C: -4.91%

ecur-506 fda drug treatment clearance for application trial
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
CRBU | $3.905 -0.13% 360K twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 1.41% C: -2.17%

cb-010 fda lupus clearance
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
ANGO | $6.325 -0.08% 59K twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 12.5% C: 0.0%

treatment clearance system
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
HAE | $85.33 0.53% 86K twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 1.54% C: 0.19%

teg fda clearance global
Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
Published: 2024-04-03 (Crawled : 23:00) - prnewswire.com
BW | News | $1.0 380K twitter stocktwits trandingview |
Electronic Technology
| | O: 1.69% H: 2.5% C: -4.17%

fda clearance system
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Published: 2024-04-01 (Crawled : 19:00) - biospace.com/
BAX | News | $39.56 0.1% 520K twitter stocktwits trandingview |
Health Technology
| | O: 1.78% H: 1.13% C: 0.11%

fda clearance therapy
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $105.52 -0.36% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 0.0% C: -1.38%

fda test rapid blood clearance
GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
GEHC | $85.42 0.31% 320K twitter stocktwits trandingview |
n/a
| | O: 0.09% H: 0.32% C: -1.7%

fda health clearance
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
STIM | $3.93 -0.76% 5.5K twitter stocktwits trandingview |
Health Technology
| | O: 13.48% H: 3.96% C: -1.88%

neurostar fda depression treatment clearance advanced therapy
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
NVS | News | $92.61 -0.51% 430K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.28% C: -0.01%
MOR | News | $18.0 -0.22% 66K twitter stocktwits trandingview |
Health Technology
| | O: 0.94% H: 0.11% C: -0.11%

acquisition clearance novartis
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
VRTX | $393.86 0.19% 160K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 0.88% C: 0.02%

vx-407 fda drug disease kidney treatment clearance application
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5
Published: 2024-03-14 (Crawled : 21:00) - globenewswire.com
ISRG | $374.33 0.04% 590K twitter stocktwits trandingview |
Health Technology
| | O: 3.6% H: 0.0% C: -0.47%

fda clearance
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
Published: 2024-03-13 (Crawled : 12:30) - globenewswire.com
CMND | News | $1.2 0.84% 23K twitter stocktwits trandingview |
n/a
| | O: -2.72% H: 1.4% C: -4.9%

clearance trial
Cepheid Receives FDA Clearance for Xpert® Xpress GBS
Published: 2024-03-11 (Crawled : 13:00) - biospace.com/
DHR | $237.72 -0.7% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.59% C: 0.12%

xpert fda clearance
Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers
Published: 2024-03-11 (Crawled : 12:30) - globenewswire.com
APRE | $5.73 89 twitter stocktwits trandingview |
Health Technology
| | O: 13.32% H: 0.25% C: -16.21%

apr-1051 fda clearance therapeutics
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
PTGX | $25.61 0.16% 79K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.45% C: -0.66%

jnj-2113 first year presentation psoriasis one clearance meeting skin
Gainers vs Losers
82% 18%

Top 10 Gainers
AGBA | $0.7995 99.88% 73M twitter stocktwits trandingview |
Finance

BPTH | $6.21 91.67% 58M twitter stocktwits trandingview |
Health Technology

INVO | $1.36 78.95% 3.6M twitter stocktwits trandingview |
Health Technology

TIRX | $0.8258 70.34% 50M twitter stocktwits trandingview |

ISPC | $0.307 44.13% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SINT | $0.0519 39.14% 350M twitter stocktwits trandingview |
Health Technology

VTNR S | $1.295 32.25% 5.5M twitter stocktwits trandingview |
Industrial Services

ALRN | $5.53 30.12% 250K twitter stocktwits trandingview |
Health Technology

HOLO | $2.86 27.68% 28M twitter stocktwits trandingview |

XPON | $2.43 25.91% 7.2M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.